Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience

Pancreatic adenocarcinoma is the fourth leading cause of cancer death. Recently, MM-398 (nanoliposomal irinotecan) was shown to be associated with significant improvement in outcome measures with acceptable toxicities when combined with 5-fluorouracil (5-FU)/leucovorin (LV) compared to 5-FU/LV alone...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Med Oncol
Main Authors: Bupathi, M., Ahn, D. H., Wu, C., Ciombor, K. K., Stephens, J. A., Reardon, J., Goldstein, D. A., Bekaii-Saab, T.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4976592/
https://ncbi.nlm.nih.gov/pubmed/26995224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-016-0753-9
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker